p38α-Selective Mitogen-Activated Protein Kinase Inhibitor SD-282 Reduces Inflammation in a Subchronic Model of Tobacco Smoke-Induced Airway Inflammation-Reference-Cited by-同舟云学术

p38α-Selective Mitogen-Activated Protein Kinase Inhibitor SD-282 Reduces Inflammation in a Subchronic Model of Tobacco Smoke-Induced Airway Inflammation

Published:2007-12-04 Issue:3 Volume:324 Page:921-929
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Medicherla Satyanarayana,Fitzgerald Mary F.,Spicer Dianne,Woodman Paul,Ma Jing Y.,Kapoun Ann M.,Chakravarty Sarvajit,Dugar Sundeep,Protter Andrew A.,Higgins Linda S.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference41 articles.

1. Role of p38 MAP Kinase in the Development of Acute Lung Injury

2. Retraction Notice: Emerging Targets for COPD Therapy

3. Targeting histone deacetylase 2 in chronic obstructive pulmonary disease treatment

4. Steroid-resistant Inflammation in a Rat Model of Chronic Obstructive Pulmonary Disease Is Associated with a Lack of Nuclear Factor-κB Pathway Activation

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A first-in-kind MAPK13 inhibitor that can correct stem cell reprogramming and post-injury disease;2024-08-22

2. MAPK13 controls structural remodeling and disease after epithelial injury;2024-06-03

3. Mitogen-activated protein kinase-guided drug discovery for post-viral and related types of lung disease;European Respiratory Review;2024-01-31

4. A potent MAPK13-14 inhibitor prevents airway inflammation and mucus production;American Journal of Physiology-Lung Cellular and Molecular Physiology;2023-12-01

5. A potent MAPK13-14 inhibitor prevents airway inflammation and mucus production;2023-05-27